#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Cardiology Review - Issue 1/2017

7

Cardiotoxicity – basic terms and mechanisms

R. Pudil

11

Cardiotoxicity of anti-cancer drugs in experimental settings

M. Adamcová, M. Štěrba

14

Cardiotoxicity of anticancer treatment in patients with ovarian cancer

I. Sedláková, R. Pudil, R. Praus, V. Študent, J. Špaček

22

Late consequences of cardiotoxicity

L. Elbl

30

Cardiotoxicity – current guidelines

R. Pudil

34

Cardiotoxicity in haemato-oncological patients

B. Mladosievičová

39

Rivaroxaban – pharmacological profile

K. Urbánek

45

Edoxaban – pharmacological profile

R. Lábrová, K. Lábr

51

Diuretics and mineralocorticoid receptor antagonists in the therapy of chronic heart failure with reduced left ventricular ejection fraction

G. Mairgani, F. Málek

56

Modern antithrombotic treatment after ACS – do we use it adequately?

J. Špinar, J. Vítovec

62

COSYREL – a drug for patients with coronary artery disease and heart failure

J. Špinar, J. Vítovec

68

Beta-blockers in chronic heart failure as recorded in the FAR NHL registr

K. Lábr, J. Špinar, J. Pařenica, L. Špinarová, F. Málek, M. Špinarová, O. Ludka, Jiří Jarkovský, K. Benešová, R. Lábrová

Cardiology Review

Issue 1

2017 Issue 1

Most read in this issue

#ADS_BOTTOM_SCRIPTS#